Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Rex

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Cancer|June 2, 2005
Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemiaM Cecilia Dignani, John H Rex, Ka-Wah Chan, et al.
Journal of Clinical Microbiology|September 8, 2005
Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasisAnnie Philip, Zekaver Odabasi, Gloria Matiuzzi, et al.
Medicine|June 7, 2003
Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiologyLibsen J Rodríguez-Adrián, Robert T King, Luis G Tamayo-Derat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2003
Guidelines for treatment of candidiasisPeter G Pappas, John H Rex, Jack D Sobel, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System CoccidioidomycosisNathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, et al.
The Journal of Infectious Diseases|December 15, 2017
Reply to Paul and LeiboviciHelen W Boucher, Paul G Ambrose, Henry F Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial ResistanceJohn H Rex, George H Talbot, Mark J Goldberger, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2026
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofimKaren Cornelissen, John H Rex, Daniela Zinzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2002
Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic moldsElias J Anaissie, Shawna L Stratton, Maria Cecilia Dignani, et al.
Blood|December 7, 2002
Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignanciesElias J Anaissie, Shawna L Stratton, M Cecilia Dignani, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Cancer|June 2, 2005
Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemiaM Cecilia Dignani, John H Rex, Ka-Wah Chan, et al.
Journal of Clinical Microbiology|September 8, 2005
Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasisAnnie Philip, Zekaver Odabasi, Gloria Matiuzzi, et al.
Medicine|June 7, 2003
Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiologyLibsen J Rodríguez-Adrián, Robert T King, Luis G Tamayo-Derat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2003
Guidelines for treatment of candidiasisPeter G Pappas, John H Rex, Jack D Sobel, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System CoccidioidomycosisNathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, et al.
The Journal of Infectious Diseases|December 15, 2017
Reply to Paul and LeiboviciHelen W Boucher, Paul G Ambrose, Henry F Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial ResistanceJohn H Rex, George H Talbot, Mark J Goldberger, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2026
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofimKaren Cornelissen, John H Rex, Daniela Zinzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2002
Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic moldsElias J Anaissie, Shawna L Stratton, Maria Cecilia Dignani, et al.
Blood|December 7, 2002
Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignanciesElias J Anaissie, Shawna L Stratton, M Cecilia Dignani, et al.
Pageof 10